Cognizant Q3 2026: Financial Services Carries the Quarter
As seen on the 24/7 Wall St. homepage on October 29, 2026.
One segment is holding this company up: Financial Services grew 12% year over year, covering declines in Health Sciences and Products and Resources. Cognizant still backed full-year adjusted EPS growth of 8% to 10%.
Continue ReadingShow less
Cognizant posted Q3 2026 adjusted EPS of $1.49, beating expectations, with revenue of $5.66 billion also ahead of estimates.
Financial Services grew 12% year over year, its third straight quarter of double-digit growth, while Health Sciences and Products and Resources both declined.
Adjusted operating margin expanded 30 basis points to 16.3%, a seventh consecutive quarter of year-over-year improvement despite Project Leap restructuring charges.
Sponsored
Management reaffirmed full-year 2026 adjusted diluted EPS guidance of $5.72 to $5.79, representing 8% to 10% growth.
Q3 bookings declined 7% year over year even as trailing-twelve-month large deal bookings grew 9%. Investors ignoring that divergence miss the test of whether Financial Services can carry the rest of the portfolio.
Mentioned: CTSH